AIO-Studien-gGmbH

Generating summary...

AIO-Studien-gGmbH provides practical support for investigators in the design, implementation, and management of clinical studies in internal oncology and related areas. The organization conducts GCP-compliant studies (AMG and MPG) across Phases I–IV, including studies on quality of life, adverse-event management, registry studies, and clinical evaluations of medical devices. It builds and maintains study logistics (laboratories, pharmacies, pathology) and implements quality assurance and quality control systems (audits, inspections, monitoring) at trial centers, alongside data analysis, reporting, and publication of results. The company advises on study design, planning, biostatistics, translational research, and handles total cost calculations, contract management, vendor management, and fundraising. Originating from the study center of the Arbeitsgemeinschaft Internistische Onkologie within the Deutsche Krebsgesellschaft e.V., AIO-Studien-gGmbH was registered in Berlin in 2007 and operates with a nonprofit purpose to promote science and research in internal oncology, serving as sponsor and study management partner both nationally and internationally and coordinating with international partners and service providers to support project completion.